Novogene Co., Ltd. (SHA:688315)

China · Delayed Price · Currency is CNY

13.26

+0.36 (2.79%)

Aug 4, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Life Science Basic Research Service	791.82M				655.75M		678.18M	552.25M	356.63M
Medical Research and Technical Services	289.20M				273.10M		306.22M	272.44M	234.89M
Sequencing Platform Services	1.06B				704.33M		384.89M	203.76M	141.74M
Others	58.99M				230.49M		165.53M	24.22M	5.95M
Total	2.20B				1.86B		1.53B	1.05B	739.21M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mainland China	1.11B				1.20B		1.06B	738.25M	577.01M
Hong Kong, Macao, Taiwan and Overseas	1.09B				665.79M		-	-	-
America	-				-		216.94M	120.91M	67.85M
Europe	-				-		96.66M	76.71M	14.59M
Singapore	-				-		53.52M	49.31M	21.22M
Asia-Pacific (Except Singapore and China)	-				-		103.09M	67.50M	58.54M
Total	2.20B				1.86B		1.53B	1.05B	739.21M